Study of the Vascular Effects of Serelaxin

Clinical trial NCT01979614 · COMPLETED

Trial details

NCT number: NCT01979614
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2014-02-03
Primary completion: 2016-08-17
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.